MedPath

Observational Study on the Safety, Health Improvement and Well-being of a Prolonged Fasting

Recruiting
Conditions
Prevention in healthy subjects
E66
I10
E88.9
Obesity
Essential (primary) hypertension
Metabolic disorder, unspecified
Registration Number
DRKS00021023
Lead Sponsor
Clínica Buchinger Wilhelmi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

1. Age 18-90 years
2. beginning inpatient treatment or hospital stay (first 24 h) at the Clínica Buchinger Wilhelmi in Marbella
3. present written declaration of consent

Exclusion Criteria

1. no adequate linguistic communication possible
2. dementia or other cognitive impairment
3. existing pregnancy or breastfeeding period
4. participation in another study

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
therapeutic and preventive efficiency regarding:<br>- risk<br>-blood parameters (at the beginning and the end of the therapy)<br>- drug intake<br>- weight reduction and maintainance (daily during the inpatient stay and until 11 months afterwards by survey)<br>- reduction of the waist circumference<br>- blood pressure lowering (daily during the inpatient stay and until 11 months afterwards by survey)<br>- behavioral factors before and up to 11 months afterwards by survey<br>- general subjective well-being<br>- documentation of the diagnosis at the beginning of the stay
Secondary Outcome Measures
NameTimeMethod
Safety of the Buchinger Wilhelmi Program:<br>- documentation of disorders and fasting crises during the inpatient stay<br>- effects that possibly stay in relation with the therapy are documented by survey up to 11 months afterwards<br>- well-being: visual scalas to capture the physical and emotional well-being daily during the stay<br>- documentation of the quality of life before and up to 11 months afterwards by survey
© Copyright 2025. All Rights Reserved by MedPath